Skip to Primary Navigation

HRSA finalizes 340B rebate pilot roster ahead of 2027 launch

HRSA identified 10 drugmakers and 21 drugs for its revised 340B rebate pilot, reviving debate over oversight, costs and provider access.

Article label: Quick Read
Premium article

The Health Resources and Services Administration (HRSA) has named 10 pharmaceutical manufacturers and 21 drugs that will participate in its revised 340B Rebate Model Pilot Program, scheduled to begin January 1, 2027.

HRSA published the participant list on October 2, providing details on a program that will replace traditional upfront

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 6,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience